Capital Analysts LLC’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-198
Closed -$1K – 717
2019
Q1
$1K Sell
198
-300
-60% -$3.31K ﹤0.01% 644
2018
Q4
$5K Sell
498
-86,888
-99% -$969K ﹤0.01% 517
2018
Q3
$1.25M Buy
87,386
+4,793
+6% +$65.1K 0.14% 133
2018
Q2
$991K Buy
82,593
+1,508
+2% +$18.6K 0.12% 146
2018
Q1
$1M Buy
81,085
+3,533
+5% +$50.2K 0.12% 143
2017
Q4
$1.13M Buy
77,552
+3,769
+5% +$52.4K 0.14% 125
2017
Q3
$1.05M Buy
73,783
+3,392
+5% +$43.9K 0.14% 119
2017
Q2
$898K Buy
70,391
+6,663
+10% +$80.9K 0.13% 131
2017
Q1
$808K Buy
+63,728
New +$756K 0.13% 119

Other funds holding MDRX

Capital Analysts LLC's MDRX Position: Q2 2019 in Review

Capital Analysts LLC sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2019, closing a stake of 198 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in MDRX in Q1 2017 and held it in 9 quarters. The position peaked at $1.25M in Q3 2018. 224 funds tracked by Wall St. Rank hold MDRX as of Q2 2019.

  • Capital Analysts LLC reported no remaining Veradigm Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Capital Analysts LLC sold 198 Veradigm Inc. Common Stock shares in Q2 2019, an estimated $1K.
  • Capital Analysts LLC first reported a position in Veradigm Inc. Common Stock in Q1 2017 and held it in 9 quarters.
  • Capital Analysts LLC's Veradigm Inc. Common Stock position peaked at $1.25M in Q3 2018.
  • 224 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2019.

Based on Capital Analysts LLC's 13F filing for Q2 2019, filed 13 Aug 2019.